FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

386898005: Nevirapine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461076017 Nevirapine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481012015 Nevirapine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nevirapine Is a Substance with reverse transcriptase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Nevirapine Is a Allergen class false Inferred relationship Existential restriction modifier
Nevirapine Is a Drug allergen false Inferred relationship Existential restriction modifier
Nevirapine Has disposition Reverse transcriptase inhibitor true Inferred relationship Existential restriction modifier
Nevirapine Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Nevirapine Is a Heterocyclic compound true Inferred relationship Existential restriction modifier
Nevirapine Is a Substance with transferase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Nevirapine Is a Substance with cyclopropane structure true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing nevirapine Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing lamivudine and nevirapine and zidovudine Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing lamivudine and nevirapine and stavudine Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Allergy to nevirapine Causative agent True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing nevirapine in oral dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 2
Nevirapine hemihydrate Is a False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 2
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 2
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 1
Nevirapine hemihydrate Is modification of True Nevirapine Inferred relationship Existential restriction modifier
Product containing only lamivudine and nevirapine and stavudine (medicinal product) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing only lamivudine and nevirapine and zidovudine (medicinal product) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 2
Nevirapine Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 2
Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing only nevirapine in oral dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier 3
Product containing precisely nevirapine 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier 1
Measurement of nevirapine (procedure) Component True Nevirapine Inferred relationship Existential restriction modifier 2
Measurement of concentration of nevirapine in serum specimen (procedure) Component True Nevirapine Inferred relationship Existential restriction modifier 3
Measurement of nevirapine (procedure) Component False Nevirapine Inferred relationship Existential restriction modifier
Measurement of concentration of nevirapine in serum specimen (procedure) Component False Nevirapine Inferred relationship Existential restriction modifier
Mass concentration of nevirapine in serum (observable entity) Component True Nevirapine Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 200mg tablet - product Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 50mg/5mL oral suspension - product Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg/5mL oral suspension Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine hemihydrate Is a False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Amarox Ltd) Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Amarox Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (PI) (Dowelhurst Ltd) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (PI) (Dowelhurst Ltd) 60 tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 50mg/5ml oral suspension 240 ml Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets 60 tablet Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) 240 ml Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) 60 tablet 6 x 10 tablets Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) 240 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 50mg/5ml oral suspension 240 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets 60 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (PI) (Dowelhurst Ltd) Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (PI) (Dowelhurst Ltd) 60 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets 14 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) 14 tablet 2 x 7 tablets Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 100mg modified-release tablets Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 100mg modified-release tablets Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 50mg modified-release tablets Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 50mg modified-release tablets Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 100mg modified-release tablets (Boehringer Ingelheim Ltd) Has active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 100mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) Has active ingredient False Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 100mg modified-release tablets 90 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Nevirapine 50mg modified-release tablets 180 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 100mg modified-release tablets (Boehringer Ingelheim Ltd) 90 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has specific active ingredient True Nevirapine Inferred relationship Existential restriction modifier

Page 1 of 2 End

This concept is not in any reference sets

Back to Start